Disease | vascular disease |
Phenotype | C0598608|hyperhomocysteinemia |
Sentences | 20 |
PubMedID- 24386282 | In other studies, fa acid supplementation has been reported to improve endothelial dysfunction in hyperhomocysteinemia (hhcy) patients with vascular disease [41], [42] including asymptomatic hhcy subjects [43], [44]. |
PubMedID- 25822522 | hyperhomocysteinemia, which is associated with vascular diseases [24,25], birth defects such as spina bifida [26], and neurodegenerative diseases such as alzheimer’s disease [27]. |
PubMedID- 23791689 | Objective: hyperhomocysteinemia is associated with an elevated cardiovascular disease risk. |
PubMedID- 23936148 | hyperhomocysteinemia has been associated with cardiovascular disease in several prospective studies [18] and numerous explanatory pathomechanisms have been proposed [19-21]. |
PubMedID- 24847701 | Hyperglycemia, dyslipidemia and hyperhomocysteinemia are associated with both adult cardiovascular disease (cvd) and having a child with a congenital heart disease (chd). |
PubMedID- 25577237 | But other findings showed that hyperhomocysteinemia is a predictor of cardiovascular disease in patients with renal failure as well as chronic stable renal transplant recipients independently of renal function and this is contradictory to the assumption that hyperhomocysteinemia is caused by renal dysfunction [2]. |
PubMedID- 20227264 | hyperhomocysteinemia is associated with cerebro- and cardiovascular disease in industrialized countries, mostly resulting from protein rich diet and sedentary life style. |
PubMedID- 22520390 | Conclusion: the present study confirms high hyperhomocysteinemia prevalence in patients with extracranial cerebrovascular disease, although no relationship between plaque complication phenomena and this cardiovascular risk factor was observed. |
PubMedID- 23569455 | Many clinical and epidemiological studies published during the last three decades have shown that even mild hyperhomocysteinemia is associated with vascular disease [6,8,9,10]. |
PubMedID- 22573925 | (2) several studies have elucidated an association of hyperhomocysteinemia with vascular disease independent of the conventional factors. |
PubMedID- 26301043 | Hypertension, diabetes mellitus, hypercholesterolemia, and hyperhomocysteinemia favour the occurrence of atherosclerosis, cardiovascular diseases, and stroke and represent important risk factors for vad [54]. |
PubMedID- 23912038 | High levels of homocysteine (hcy), known as hyperhomocysteinemia are associated with neurovascular diseases. |
PubMedID- 20980407 | Folic acid supplementation is regarded as a promising approach for prevention and treatment of cardiovascular disease associated with hyperhomocysteinemia due to its hcy-lowering effect. |
PubMedID- 24231341 | hyperhomocysteinemia (hhcy) is associated with cardiovascular disease, atherosclerosis and reactive oxygen species generation. |
PubMedID- 20091801 | Perturbations of homocysteine metabolism, particularly intracellular and subsequently circulating accumulation of homocysteine (i.e., hyperhomocysteinemia), are associated with vascular disease risk, as well as other pathologies. |
PubMedID- 25194809 | Background and aims: hyperhomocysteinemia (hhcy) is associated with cardiovascular diseases and is thought to induce endogenous oxidative stress and causes many cellular damages. |
PubMedID- 22886392 | High levels of homocysteine (hcy), known as hyperhomocysteinemia (hhcy), are associated with cerebrovascular diseases, such as vascular dementia, stroke, and alzheimer's disease. |
PubMedID- 19267198 | Background: homocysteine levels in circulation are determined by several factors and hyperhomocysteinemia is reportedly associated with cardiovascular diseases and dementia. |
PubMedID- 19913585 | An elevated level of homocysteine (hcy), known as hyperhomocysteinemia (hhcy), was associated with neurovascular diseases. |
PubMedID- 24783194 | hyperhomocysteinemia is strongly associated with cardiovascular diseases. |
Page: 1